PEC vs Handa Pharmaceuticals: monthly revenue

Monthly revenue and year-on-year change for PEC (6446) and Handa Pharmaceuticals (6620) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ PEC ━ Handa Pharmaceuticals

0%+108%-89%25/1026/0126/0426/0726/10

Monthly revenue history

MonthPECYoYHanda PharmaceuticalsYoY
Oct 2026NT$2.84 billion+102.0%NT$65.9 million-24.8%
Sep 2026NT$2.64 billion+100.0%NT$70.4 million-20.1%
Aug 2026NT$2.62 billion+105.4%NT$66.7 million-79.9%
Jul 2026NT$2.51 billion+92.6%NT$69.7 million+0.6%
Jun 2026NT$2.33 billion+94.9%NT$80.9 million-21.8%
May 2026NT$2.46 billion+108.5%NT$71.3 million-24.4%
Apr 2026NT$2.06 billion+68.3%NT$62.1 million-88.9%
Mar 2026NT$1.94 billion+64.4%NT$78.7 million+11.0%
Feb 2026NT$1.6 billion+56.7%NT$55 million+4.2%
Jan 2026NT$1.58 billion+49.8%NT$75.7 million+32.2%
Dec 2025NT$1.92 billion+69.9%NT$136.8 million+106.5%
Nov 2025NT$1.55 billion+53.0%NT$75.8 million+35.6%
Oct 2025NT$1.4 billion+53.6%NT$87.6 million+34.4%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16